Deep Intelligent Pharma

Deep Intelligent Pharma Co., Ltd. is a national high-tech enterprise in the field of artificial intelligence and a global leading provider of integrated AIaaS solutions. The company is committed to building an end-to-end AI-driven system platform to empower and accelerate the comprehensive intelligent digital transformation of pharmaceutical companies worldwide. It was honored as one of the "Top 100 Most Innovative Companies in China in 2018" and ranked among the top. Deep Intelligent Pharma's "Pharma R&D Cloud" and its solutions are serving more than 450 pharmaceutical companies globally, including multinational corporations such as Bayer, Johnson & Johnson, Merck, GSK, Lundbeck, Abbott, as well as international innovative pharmaceutical companies like BeiGene. Among these, the artificial intelligence small molecule drug design and generation platform independently developed by Deep Intelligent Pharma shortens the delivery time for structures from target to the first batch of lead compounds (full chemical space) to within one month, serving over 20 global publicly listed pharmaceutical companies and research institutions.